Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:53 AM
Ignite Modification Date:
2025-12-25 @ 12:53 AM
NCT ID:
NCT00269867
Eligibility Criteria:
Inclusion Criteria:
* Patients with active Rheumatoid Arthritis despite treatment with methotrexate
* Diagnosed with Rheumatoid Arthritis at least 6 months prior to screening
* Having active disease at the time of screening and pre-infusion as defined by having at least 6 or more swollen joints and 6 or more tender joints
* Using methotrexate for at least 3 months prior to study enrollment
Exclusion Criteria:
* Patients having any systemic inflammatory condition
* Having Lyme disease or a rheumatic disease other than Rheumatoid Arthritis
* Who have used Disease-Modifying Antirheumatic Drugs (DMARDs) other than methotrexate within 4 weeks prior to screening
* Who have used corticosteroids within 4 weeks prior to screening
* Having received previous administration of infliximab
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT00269867
Study Brief:
Protocol Section:
NCT00269867